FIELD: medicine; chemical and pharmaceutical industry.
SUBSTANCE: pharmaceutical composition of anti-inflammatory, antibacterial, antifungal, regenerative action for external application contains 0.01–1 wt % gentamycin, 0.05–1.5 wt % mometasone, 0.1–5 wt % econazole or pharmaceutically acceptable salts thereof, 0.5–10 wt % dexpanthenol, as well as additional excipients, wherein mometasone or its pharmaceutically acceptable salt in the composition has particle size of less than 20 mcm for 100 % particles and less than 10 mcm for 90 % particles, econazole or its pharmaceutically acceptable salt in the composition has a particle size of less than 100 mcm for 100 % particles and less than 50 mcm for 90 % particles. Also disclosed is use of a pharmaceutical composition for treating skin diseases and conditions, selected from dermatoses of inflammatory genesis with concomitant bacterial and mycotic infection, dermatoses with high probability of secondary bacterial and mycotic infection, simple dermatitis, allergic dermatitis, atopic dermatitis, limited neurodermatitis, eczema, dermatophytosis, simple chronic lichen.
EFFECT: disclosed is a combined pharmaceutical composition for external application.
8 cl, 2 tbl, 1 ex
